Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma
Weijie Zhong(First Affiliated Hospital of Jinan University), Qingshan Li(Shanxi University of Traditional Chinese Medicine)
Cited by 34
Related Papers
Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma
|Cancer Cell International|2021|10